Clinitas
Commercial- Indications
- Dry eye disease
Company intelligence / Profile preview
Altacor has a portfolio of commercialized products in the UK and Ireland for dry eye and surgical use. Its Clinitas line addresses moderate dry eye with high hyaluronic acid content. BioLon® viscoelastic device supports cataract surgery. The company continues to develop new products targeting unmet needs in ophthalmology, including orphan indications and glaucoma. It has demonstrated strong performance in the UK market and aims for European/global expansion. No recent clinical trial results are publicly detailed.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altacor.